Evidence map›Paper›PMID 26061650›Full record

ArticleEpigenetics2015

Beckwith-Wiedemann syndrome prenatal diagnosis by methylation analysis in chorionic villi.

Leda Paganini, Nicole Carlessi, Laura Fontana, Rosamaria Silipigni, Silvia Motta, Stefano Fiori, Silvana Guerneri, Faustina Lalatta, Anna Cereda, Silvia Sirchia and 2 more

Abstract read
In one paragraph

Article in Epigenetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Extensive Placental Methylation Profiling in Normal Pregnancies.International journal of molecular sciences · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Role of DNA methylation in imprinting disorders: an updated review.Journal of assisted reproduction and genetics · 2017
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Leda Paganinia Division of Pathology; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico; Department of Pathophysiology & Transplantation; Università degli Studi di Milano ; Milano , Italy.
Nicole Carlessi
Laura Fontana
Rosamaria Silipigni
Silvia Motta
Stefano Fiori
Silvana Guerneri
Faustina Lalatta
Anna Cereda
Silvia Sirchia
Monica Miozzo
Silvia Tabano

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Beckwith-Wiedemann syndrome (BWS) is an imprinting disorder that can be prenatally suspected or diagnosed based on established clinical guidelines. Molecular confirmation is commonly performed on amniocytes. The possibility to use fresh (CVF) and cultured (CVC) chorionic villi has never been investigated. To verify whether CVF and CVC are reliable sources of DNA to study fetal methylation, we used pyrosequencing to test the methylation level of a number of differentially methylated regions (DMRs) at several imprinted loci (ICR1, ICR2, H19, PWS/AS-ICR, GNASXL, GNAS1A, ZAC/PLAGL1, and MEST) and at non-imprinted MGMT and RASSF1A promoters. We analyzed these regions in 19 healthy pregnancies and highlighted stable methylation levels between CVF and CVC at ICR1, ICR2, GNASXL, PWS/AS-ICR, and MEST. Conversely, the methylation levels at H19 promoter, GNAS1A and ZAC/PLAGL1 were different in CVC compared to fresh CV. We also investigated ICR1 and ICR2 methylation level of CVF/CVC of 2 BWS-suspected fetuses (P1 and P2). P1 showed ICR2 hypomethylation, P2 showed normal methylation at both ICR1 and ICR2. Our findings, although limited to one case of BWS fetus with an imprinting defect, can suggest that ICR1 and ICR2, but not H19, could be reliable targets for prenatal BWS diagnosis by methylation test in CVF and CVC. In addition, PWS/AS-ICR, GNASXL, and MEST, but not GNAS1A and ZAC/PLAGL1, are steadily hemimethylated in CV from healthy pregnancies, independently from culture. Thus, prenatal investigation of genomic imprinting in CV needs to be validated in a locus-specific manner.

Indexed as

DNA MethylationPrenatal DiagnosisBeckwith-Wiedemann SyndromeCells, CulturedChorionic VilliFemaleGenomic ImprintingHumansPregnancyPromoter Regions, GeneticAngelman Syndrome; BWSARTAssisted Reproductive Technologies; ASBeckwith-Wiedemann syndromeBeckwith-Wiedemann Syndrome; CVchorionic villiChorionic Villi; CVCCultured Chorionic Villi; CVFDifferentially Methylated Regions; ICRDNA methylationFresh Chorionic Villi; DMRimprintingImprinting Control Region; IUGRIntra-Uterine Growth Restriction; MMDMultilocus Methylation Defect; PWSPrader-Willi Syndrome; SGAprenatal diagnosisSilver Russell Syndrome; UPDSmall for Gestational Age; SRSUltra Sound.Uniparental Disomy; US

Identifiers

PMID26061650
PMCPMC4622958

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.